Aldosterone and the heart

Trends in Endocrinology and Metabolism

Volumn 11, Issue 6, 2000, Pages 224-226

  Young, Morag ^a   Funder, John W ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; CANRENOATE POTASSIUM; CORTICOSTERONE; DEOXYCORTICOSTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HORMONE RECEPTOR BLOCKING AGENT; MINERALOCORTICOID; OXPRENOATE POTASSIUM; POTASSIUM; SPIRONOLACTONE;

ADRENAL CORTEX; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COLON; DRUG ANTAGONISM; DRUG MECHANISM; ENZYME ACTIVITY; GYNECOMASTIA; HEART FAILURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE SYNTHESIS; HUMAN; KIDNEY; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SODIUM TRANSPORT; SWEAT GLAND; TREATMENT OUTCOME;

ALDOSTERONE; ANIMALS; HEART; HUMANS;

EID: 0033859180     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(00)00270-8     Document Type: Review

References (35)

1. Pitt B.et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New Engl. J. Med. 341:1999;709-717.
2. Takeda Y.et al. Production of aldosterone in isolated rat blood vessels. Hypertension. 25:1995;170-173.
3. Blair-West J.R.et al. Increased aldosterone secretion during sodium depletion with inhibition of renin release. Am. J. Physiol. 224:1973;1409-1414.
4. Okubo S.et al. Angiotensin- independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion. J. Clin. Invest. 99:1997;855-860.
5. Staessen J.et al. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J. Endocrinol. 91:1981;457-465.
6. Gomez-Sanchez E.P.et al. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats. Am. J. Physiol. 262:1992;E96-E99.
7. Brilla C.G., Weber K.T. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J. Lab. Clin. Med. 120:1992;893-901.
8. Young M.et al. Mineralocorticoids, hypertension, and cardiac fibrosis. J. Clin. Invest. 93:1994;2578-2583.
9. Young M.J., Funder J.W. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt induced cardiac fibrosis. Am. J. Physiol. 34:1996;E883-888.
10. Brilla C.J.et al. Anti-fibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am. J. Cardiol. 71:1993;12A-16A.
11. Young M.et al. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states. Am. J. Physiol. 269:1995;E657-E662.
12. Gomez-Sanchez E.P. Mineralocorticoid modulation of central control of blood pressure. Steroids. 60:1995;69-72.
13. Campbell S.E.et al. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J. Mol. Cell. Cardiol. 27:1995;1545-1560.
14. Robert V.et al. Biological determinants of aldosterone-induced car-diac fibrosis in rats. Hypertension. 26:1995;971-978.
15. Kagawa C.M.et al. Relationship of plasma aldadiene levels and antimineralocorticoid effects of spironolactone in the laboratory. Proc. Soc. Exp. Biol. Med. 115:1964;873-880.
16. Wehling M. Novel aldosterone receptors. specificity-conferring mechanism at the level of the cell membrane Steroids. 59:1994;160-163.
17. Chen S.et al. Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2514-2519.
18. Naray-Fejes-Toth A.et al. sgk is an aldosterone-induced kinase in the renal collecting duct. J. Biol. Chem. 274:1999;16973-16978.
19. Sun Y.et al. Inhibition of angiotensin converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. J. Lab. Clin. Med. 126:1995;95-101.
20. Brown L.et al. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system. J. Am. Soc. Nephrol. 10:1999;S143-S148.
21. Robert V.et al. Angiotensin ATI receptor subtype as a cardiac target of aldosterone. role in aldosterone- salt-induced fibrosis Hypertension. 33:1999;981-986.
22. Guarda E.et al. Endothelial cell induced modulation of cardiac fibroblast collagen metabolism. Cardiovasc. Res. 27:1993;1004-1008.
23. Fullerton M.J., Funder J.W. Aldosterone and cardiac fibrosis. in vitro studies Cardiovasc. Res. 28:1994;1863-1867.
24. Kohler E.et al. Does aldosterone-induced cardiac fibrosis involve direct effects on cardiac fibroblasts? J. Vasc. Res. 33:1996;315-326.
25. Nicoletti A., Michel J-B Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc. Res. 41:1999;532-543.
26. Alzamora R.et al. Role of 11beta-hydroxysteroid dehydrogenase in nongenomic aldosterone effects in human arteries. Hypertension. 35:2000;1099-1104.
27. + pump activation during short-term exposure of cardiac myocytes to aldosterone. Am. J. Physiol. 274:1998;C175-C181.
28. Hatakeyama H.et al. Vascular aldosterone. biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells J. Biol. Chem. 269:1994;24316-24320.
29. Gomez-Sanchez C.E.et al. Aldosterone biosynthesis in the rat brain. Endocrinology. 138:1997;3369-3373.
30. Takeda Y.et al. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology. 2000;. (in press).
31. Silvestre J.-S.et al. Activation of cardiac aldosterone production in rat myocardial infarction. Circulation. 99:1999;2694-2701.
32. Takeda Y.et al. Cardiac aldosterone production in genetically hypertensive rats. Hypertension. 2000;. (in press).
33. Lombes M.et al. The mineralocorticoid receptor discriminates aldosterone from glucocorticoids inde-pendently of the 11 beta-hydroxysteroid dehydrogenase. Endocrinology. 135:1994;834-840.
34. Sato A., Funder J.W. High glucose stimulates aldosterone-induced hypertrophy via Type I mineralocorticoid receptors in neonatal rat cardiomyocytes. Endocrinology. 137:1996;4145-4153.
35. Gomez-Sanchez E.P.et al. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension. Am. J. Physiol. 258:1990;E649-E653.